Employee Benefit Plans (Tables)

3 Months Ended

Mar. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Nonvested Share Activity

The Company’s RSU, RSA, and PSA activities and related information as of and for the three months ended March 31, 2025 were as follows (in millions, except per share amounts and years):

	Outstanding RSUs, RSAs, and PSAs
	Number of Shares	Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contractual Term (In Years)	Aggregate Intrinsic Value
Balance as of December 31, 2024	19.0	$	32.53
Granted(*)	0.7	34.54
Vested	(2.1)	32.08
Cancelled	(1.3)	35.17
Balance as of March 31, 2025	16.3	$	32.47	1.1	$	591.0

________________________________

(*)    During the three months ended March 31, 2025, all of the 0.7 million shares granted were service-based awards and no performance-based awards were granted. The grant date fair value of RSUs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.

Schedule of Employee Service Share-Based Compensation, Allocation of Recognized Period Costs

Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and ESPP purchase rights was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):

	Three Months Ended March 31,
	2025		2024
Cost of revenues - Product	$	1.8	$	1.8
Cost of revenues - Service	5.2		5.5
Research and development	26.6		38.5
Sales and marketing	18.7		24.1
General and administrative	10.3		10.0
Total	$	62.6	$	79.9

Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award

The following table summarizes share-based compensation expense by award type (in millions):

	Three Months Ended March 31,
	2025		2024
Stock options	$	0.1	$	0.3
RSUs, RSAs, and PSAs	62.5		72.9
ESPP purchase rights	—		6.7
Total	$	62.6	$	79.9